Stock Market News22 hours Pfizer Stock Rises as Drug Giant Sees 2025 Revenue of $61 Billion to $64 Billion Yahoo Finance
Pfizer Stock Rises as Drug Giant Sees 2025 Revenue of $61 Billion to $64 Billion.
X11 hours Final Trade: GOOG, SAIA, X, PFE YouTube
X12 hours Pfizer climbs 4% on 2025 outlook YouTube
X15 hours Comments From Trump, Pfizer CEO Hit UnitedHealth, CVS Stock Yahoo Finance
X17 hours Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC
X18 hours Pfizer Inc. (PFE) Full-Year 2025 Financial Guidance Conference Call (Transcript) Seeking Alpha
X18 hours Guggenheim: Can see Pfizer reaching $10 billion in sales by 2030 YouTube
X20 hours Pfizer 2025 profit forecast soothes investor jitters as it pursues turnaround Investing.com
X20 hours Pfizer Stock Jumps On Mixed, But ‘Marginally Encouraging,’ 2025 Outlook Investor's Business Daily
X21 hours Stocks making the biggest moves premarket: Pfizer, Tesla, SolarEdge, Red Cat and more CNBC
X21 hours Pfizer Sees 2025 Revenue in Line With Wall Street Views The Wall Street Journal
X21 hours AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? Investor's Business Daily
X21 hours Nvidia, Evgo and Affirm fall premarket; Pfizer and SolarEdge rise Investing.com
X22 hours Pfizer forecasts in line 2025 profit as it seeks turnaround Investing.com
X22 hours Pfizer Sees 2025 Revenue in Line With Wall Street Views Yahoo Finance
X22 hours Pfizer projects 2025 earnings to align with expectations Investing.com
X22 hours Pfizer forecasts 2025 profit in line with expectations as it seeks turnaround CNBC
X22 hours Pfizer forecasts 2025 profit in line with expectations Investing.com
X24 hours These Stocks Are Moving the Most Today: Nvidia, Tesla, Broadcom, Pfizer, EVgo, Teva, SolarEdge, Red Cat, and More Yahoo Finance
X1 day Stocks to Watch Tuesday: Pfizer, Alibaba, Super Micro, Affirm Yahoo Finance
X2 days What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday? Yahoo Finance
X2 days Pfizer: Lowest Levels In A Decade Is An Opportunity With A Dividend Yield Exceeding 6.5% Seeking Alpha
X3 days Pfizer: Irrational Anti-Vaccine Fear Seeking Alpha
X3 days Is Pfizer a Millionaire Maker? Yahoo Finance
X6 days How Pfizer management outplayed activist investor Starboard Yahoo Finance
X6 days Pfizer (PFE) Stock Falls Amid Market Uptick: What Investors Need to Know Zacks
X7 days Pfizer: Peer-Leading Dividend And Potential Substantial Shareholder Returns Seeking Alpha
X7 days Amazon, Pfizer execs seek common ground with RFK Jr on climate risks to health Investing.com
X1 week Pfizer Stock: A Golden Buying Opportunity (Rating Upgrade) Seeking Alpha
X2 weeks Zacks.com featured highlights Urban Outfitters, Maplebear, Pfizer and Alcoa Zacks
X2 weeks Trump, RFK Jr. met with Pfizer, Lilly executives, Axios reports Investing.com
X2 weeks Pfizer: Too Cheap To Ignore Seeking Alpha
X2 weeks Pfizer Stock Falls 8% in a Month: Should You Buy the Dip? Zacks
X2 weeks Should You Forget Pfizer and Buy These Unstoppable Stocks Instead? Yahoo Finance
X2 weeks Pfizer’s New Chief Scientific Officer Charts R&D Vision For High And Low-Risk Investments Yahoo Finance
X2 weeks Zacks.com featured highlights Tyson Foods, AXIS Capital, Pfizer and General Motors Zacks
X2 weeks Mastercard, Broadcom, Pfizer Among Two Dozen Companies To Announce Dividend Increases In December Seeking Alpha
X3 weeks How Much Would It Take To Earn $100 A Month From Pfizer Stock? Yahoo Finance
X3 weeks Is This a New Reason to Buy Pfizer Stock Hand Over Fist? Yahoo Finance
X3 weeks Pfizer (PFE) Down 9.4% Since Last Earnings Report: Can It Rebound? Zacks
X3 weeks Are Investors Undervaluing Pfizer (PFE) Right Now? Zacks
X3 weeks Is Pfizer Stock in Trouble? Yahoo Finance
X3 weeks High-Quality Dividend Growth Stocks Near 52-Week Lows: Pfizer Is Fun Seeking Alpha
X3 weeks Billionaires Are Buying Up Beaten-Down Pfizer Stock. Should You Follow Their Lead? Yahoo Finance
X3 weeks Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know Zacks
X3 weeks BridgeBio Catapults After Snagging Approval For Its Rival To Pfizer’s Heart Drug Investor's Business Daily
X4 weeks Pharma Stock Roundup: EU Nod for PFE’s Hympavzi, NVS Ups Sales View Zacks
X4 weeks Pfizer Inc. (PFE) Jefferies London Healthcare Conference (Transcript) Seeking Alpha
X4 weeks Pfizer: High Dividend And Low Price Might Still Offset The Expanding Risks Seeking Alpha
X4 weeks PFE vs. NVO: Which Stock Is the Better Value Option? Zacks
X4 weeks The Zacks Analyst Blog Highlights Adobe, Pfizer, Dollar General, Snap and Ryanair Zacks
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.